IRMA - Renal Insufficiency and Anticancer Drugs

Head :
Launay-Vacher Vincent, Département de néphrologie

Last update : 09/05/2017 | Version : 1 | ID : 7961

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Renal Insufficiency and Anticancer Drugs
Sign or acronym IRMA
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation Accord CNIL
General Aspects
Medical area Cancer research
Urology, andrology and nephrology
Health determinants Iatrogenic
Medicine
Keywords cancer medications, creatinine, Prevalence, renal function
Scientific investigator(s) (Contact)
Name of the director Launay-Vacher
Surname Vincent
Address 47-83 Boulevard de l’Hopital, 75013 Paris
Email vincent.launay-vacher@psl.aphp.fr
Unit Département de néphrologie
Organization Assistance Publique - Hôpitaux de
Collaborations
Funding
Funding status Public
Details APHP
Governance of the database
Sponsor(s) or organisation(s) responsible Assistance Publique - Hôpitaux de Paris
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Not-repeated cross-sectional studies (except case control studies)
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is is made on the basis of: Medication(s) taken
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Patients presenting with a solid tumour.
Database objective
Main objective To determine the prevalence of renal impairment in cancer patients in France.
Inclusion criteria - Men or women - aged between 18 and 95 years old - patients receiving cancer treatment
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Gender Male
Woman
Geography area National
Detail of the geography area 15 medical oncology services
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2004
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 4 684
Data
Database activity Data collection completed
Type of data collected Clinical data
Clinical data (detail) Direct physical measures
Medical registration
Presence of a biobank No
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method Data collected over 2 periods of 15 consecutive days. Renal function is calculated using Cockcroft-Gault to assess the creatinine clearance rate (CICr) and an "abbreviated" or "simplified" Modification of Diet in Renal Disease (aMDRD) formulae to estimate glomerular filtration rate (GFR).
Participant monitoring No
Links to administrative sources No
Promotion and access
Promotion
Link to the document http://onlinelibrary.wiley.com/doi/10.1002/cncr.22904/pdf
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/21146120
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/18990585
Access
Terms of data access (charter for data provision, format of data, availability delay) Contact the scientist in charge.
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05